Browsing by Subject "A61K 31/5377"
Now showing items 1-8 of 8
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-03-12)Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a rifamycin derivative or a pharmaceutically acceptable salt, ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-08-10)Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a an arylphenoxypropionate derivative, an aryloxyphenoxyacetate ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-01-28)Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a an arylphenoxypropionate derivative, an aryloxyphenoxyacetate ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-09-15)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-01-16)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-10)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-05-28)A composition comprising a drug selected from the group consisting of an arylphenoxypropionate derivative, an aryloxyphenoxyacetate derivative, an aryloxyphenylacetate derivative, a substituted quinol, or a salt, hydrate, ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-05-28)A composition comprising a drug selected from the group consisting of an arylphenoxypropionate derivative, an aryloxyphenoxyacetate derivative, an aryloxyphenylacetate derivative, a substituted quinol, or a salt, hydrate, ...